Cargando…

F39. MATERNAL IMMUNE ACTIVATION MODELS: MIND YOUR CAGING SYSTEMS!

BACKGROUND: Rodent models of maternal immune activation (MIA) are increasingly used as experimental tools to study neuronal and behavioral dysfunctions in relation to infection-mediated neurodevelopmental disorders such as schizophrenia and autism. One of the most widely used MIA models is based on...

Descripción completa

Detalles Bibliográficos
Autores principales: Müller, Flavia, Weber-Stadlbauer, Ulrike, Meyer, Urs
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888582/
http://dx.doi.org/10.1093/schbul/sby017.570
_version_ 1783312556140527616
author Müller, Flavia
Weber-Stadlbauer, Ulrike
Meyer, Urs
author_facet Müller, Flavia
Weber-Stadlbauer, Ulrike
Meyer, Urs
author_sort Müller, Flavia
collection PubMed
description BACKGROUND: Rodent models of maternal immune activation (MIA) are increasingly used as experimental tools to study neuronal and behavioral dysfunctions in relation to infection-mediated neurodevelopmental disorders such as schizophrenia and autism. One of the most widely used MIA models is based on gestational administration of poly(I:C) (= polyriboinosinic-polyribocytdilic acid), a synthetic analog of double-stranded RNA that induces a cytokine-associated viral-like acute phase response. The effects of poly(I:C)-induced MIA on phenotypic changes in the offspring are known to be influenced by various factors, including the precise prenatal timing, genetic background, and immune stimulus intensity. Thus far, however, it has been ignored whether differences in laboratory housing systems can similarly affect the outcomes of MIA models. Here, we examined this possibility by comparing poly(I:C)-based MIA in two housing systems that are commonly used in preclinical rodent research, namely the individually ventilated cage (IVC) and open cage (OC) systems. METHODS: Pregnant C57BL6/N mice were kept in IVC or OC and treated with a low (1 mg/kg, i.v.) or high (5 mg/kg, i.v.) dose of poly(I:C), or with corresponding vehicle solution (pyrogen-free, sterile 0.9% NaCl; i.v.). MIA or control treatment was induced on gestation day (GD) 9 or 12, and the resulting offspring were raised and maintained in IVC or OC until adulthood for behavioral testing. An additional cohort of dams were used to assess the influence of the different caging systems on poly(I:C)-induced cytokine responses in the maternal plasma, placenta, and fetal brains 1 hr and 6 hrs post-treatment. RESULTS: Maternal administration of poly(I:C) on GD9 caused a dose-dependent increase in spontaneous abortion in IVC but not in OC system, whereas MIA in IVC systems during a later gestational time-point (GD12) did not do so. Maternal and fetal pro-inflammatory cytokine responses to poly(I:C) were markedly higher in animals kept in IVC as compared to OC systems. The efficacy of MIA to induce long-term behavioral deficits was influenced by the different housing conditions, the dosing of poly(I:C), and the precise prenatal timing. DISCUSSION: The present study identified the type of cage system as a novel factor that can confound the outcomes of MIA. Our findings thus urge the need to consider and report the kind of cages used in rodent MIA models. Providing this information seems pivotal to yield robust and reproducible results in these models.
format Online
Article
Text
id pubmed-5888582
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-58885822018-04-11 F39. MATERNAL IMMUNE ACTIVATION MODELS: MIND YOUR CAGING SYSTEMS! Müller, Flavia Weber-Stadlbauer, Ulrike Meyer, Urs Schizophr Bull Abstracts BACKGROUND: Rodent models of maternal immune activation (MIA) are increasingly used as experimental tools to study neuronal and behavioral dysfunctions in relation to infection-mediated neurodevelopmental disorders such as schizophrenia and autism. One of the most widely used MIA models is based on gestational administration of poly(I:C) (= polyriboinosinic-polyribocytdilic acid), a synthetic analog of double-stranded RNA that induces a cytokine-associated viral-like acute phase response. The effects of poly(I:C)-induced MIA on phenotypic changes in the offspring are known to be influenced by various factors, including the precise prenatal timing, genetic background, and immune stimulus intensity. Thus far, however, it has been ignored whether differences in laboratory housing systems can similarly affect the outcomes of MIA models. Here, we examined this possibility by comparing poly(I:C)-based MIA in two housing systems that are commonly used in preclinical rodent research, namely the individually ventilated cage (IVC) and open cage (OC) systems. METHODS: Pregnant C57BL6/N mice were kept in IVC or OC and treated with a low (1 mg/kg, i.v.) or high (5 mg/kg, i.v.) dose of poly(I:C), or with corresponding vehicle solution (pyrogen-free, sterile 0.9% NaCl; i.v.). MIA or control treatment was induced on gestation day (GD) 9 or 12, and the resulting offspring were raised and maintained in IVC or OC until adulthood for behavioral testing. An additional cohort of dams were used to assess the influence of the different caging systems on poly(I:C)-induced cytokine responses in the maternal plasma, placenta, and fetal brains 1 hr and 6 hrs post-treatment. RESULTS: Maternal administration of poly(I:C) on GD9 caused a dose-dependent increase in spontaneous abortion in IVC but not in OC system, whereas MIA in IVC systems during a later gestational time-point (GD12) did not do so. Maternal and fetal pro-inflammatory cytokine responses to poly(I:C) were markedly higher in animals kept in IVC as compared to OC systems. The efficacy of MIA to induce long-term behavioral deficits was influenced by the different housing conditions, the dosing of poly(I:C), and the precise prenatal timing. DISCUSSION: The present study identified the type of cage system as a novel factor that can confound the outcomes of MIA. Our findings thus urge the need to consider and report the kind of cages used in rodent MIA models. Providing this information seems pivotal to yield robust and reproducible results in these models. Oxford University Press 2018-04 2018-04-01 /pmc/articles/PMC5888582/ http://dx.doi.org/10.1093/schbul/sby017.570 Text en © Maryland Psychiatric Research Center 2018. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstracts
Müller, Flavia
Weber-Stadlbauer, Ulrike
Meyer, Urs
F39. MATERNAL IMMUNE ACTIVATION MODELS: MIND YOUR CAGING SYSTEMS!
title F39. MATERNAL IMMUNE ACTIVATION MODELS: MIND YOUR CAGING SYSTEMS!
title_full F39. MATERNAL IMMUNE ACTIVATION MODELS: MIND YOUR CAGING SYSTEMS!
title_fullStr F39. MATERNAL IMMUNE ACTIVATION MODELS: MIND YOUR CAGING SYSTEMS!
title_full_unstemmed F39. MATERNAL IMMUNE ACTIVATION MODELS: MIND YOUR CAGING SYSTEMS!
title_short F39. MATERNAL IMMUNE ACTIVATION MODELS: MIND YOUR CAGING SYSTEMS!
title_sort f39. maternal immune activation models: mind your caging systems!
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888582/
http://dx.doi.org/10.1093/schbul/sby017.570
work_keys_str_mv AT mullerflavia f39maternalimmuneactivationmodelsmindyourcagingsystems
AT weberstadlbauerulrike f39maternalimmuneactivationmodelsmindyourcagingsystems
AT meyerurs f39maternalimmuneactivationmodelsmindyourcagingsystems